 Todos Medical Ltd. OTCQB:TOMDF has revealed that its majority-owned subsidiary 3CL Pharma will present final data from the phase 2 clinical trial of Tollovir in the treatment of hospitalized severe and critical coronavirus COVID-19 patients at the upcoming Personalized Medicine World Conference PMWC. 